J Bargman
Overview
Explore the profile of J Bargman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varughese S, Bargman J
Perit Dial Int
. 2014 Dec;
34(7):815-6.
PMID: 25520492
No abstract available.
2.
Fang W, Yang X, Kothari J, Khandelwal M, Naimark D, Jassal S, et al.
Clin Nephrol
. 2008 Apr;
69(3):193-200.
PMID: 18397718
Background: Diabetes is the leading cause of end-stage renal disease (ESRD). This retrospective study investigated the long-term patient and technique survival and sought to identify the predictors of mortality in...
3.
Pliakogiannis T, Trpeski L, Taskapan H, Shah H, Ahmad M, Fenton S, et al.
Int Urol Nephrol
. 2006 Dec;
39(1):281-8.
PMID: 17171411
High Body Mass Index (BMI) has been associated with improved survival of End-Stage Renal Disease (ESRD) patients on chronic hemodialysis (HD); however, studies on the relationship of BMI with survival...
4.
Wang T, Izatt S, Dalglish C, Bargman J, Jassal S, Vas S, et al.
Clin Nephrol
. 2003 Dec;
60(5):373-4.
PMID: 14640246
No abstract available.
5.
Khandelwal M, Bailey S, Izatt S, Chu M, Vas S, Bargman J, et al.
Int J Artif Organs
. 2003 Nov;
26(10):913-7.
PMID: 14636007
Structural damage to polyurethane PD (peritoneal dialysis) catheters in patients using mupirocin ointment is widely appreciated, but damage to silicon rubber PD catheters is less well described. Ten catheters (6.6%)...
6.
Dimkovic N, Prakash S, Roscoe J, Brissenden J, Tam P, Bargman J, et al.
Nephrol Dial Transplant
. 2001 Sep;
16(10):2034-40.
PMID: 11572893
Background: During the past few decades the pattern of end-stage renal failure disease has changed with increasing number of elderly patients admitted for dialysis. In spite of their increasing number,...
7.
Prakash S, Walele A, Dimkovic N, Bargman J, Vas S, Oreopoulos D
Perit Dial Int
. 2001 Jul;
21(3):290-5.
PMID: 11475345
Objective: To compare efficacy in anemia correction and side effects of large doses of intravenous (IV) iron dextran and iron saccharate preparations in peritoneal dialysis (PD) patients. Setting: Tertiary-care teaching...
8.
Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos D
Int J Artif Organs
. 2001 Jun;
24(4):197-202.
PMID: 11394699
The authors carried out a retrospective chart review in 114 patients treated for at least two years at the Toronto Western Hospital Peritoneal Dialysis Unit and identified eight, who gained...
9.
Min F, Tarlo S, Bargman J, Poonai N, Richardson R, Oreopoulos D
Adv Perit Dial
. 2000 Oct;
16:129-33.
PMID: 11045277
Peritoneal dialysis (PD) and hemodialysis (HD) are both common forms of dialysis for patients with end-stage renal disease. A few case reports have suggested that cough is associated with PD....
10.
Billa V, Zhong A, Bargman J, Vas S, Wong P, Oreopoulos D
Perit Dial Int
. 2000 Jul;
20(3):315-21.
PMID: 10898049
Objectives: Parathyroid dysfunction continues to produce significant morbidity in dialysis patients. Since the introduction of low calcium dialysate for peritoneal dialysis (PD), no large studies have been done to determine...